Nivea described being shocked by the diagnosis. She also felt relieved to learn that the illness was not in its most aggressive phase and that her treatment plan did not require conventional chemotherapy at that time.
That distinction matters. Not receiving traditional chemotherapy does not mean that a patient is receiving no cancer treatment. CML is commonly treated with targeted medications designed to block the abnormal activity that allows leukemia cells to multiply.
Nivea has said she is taking a drug for the disease, but she has not publicly identified the specific medication. It would therefore be inaccurate to speculate about the drug or the precise type of remission she has achieved.
What she has confirmed is that the treatment is working—and that she is grateful for the result.
What chronic myeloid leukemia actually means
Chronic myeloid leukemia is a cancer affecting the blood and bone marrow.
The National Cancer Institute explains that CML causes the bone marrow to produce too many white blood cells. It usually progresses more slowly than acute forms of leukemia, although its behavior and treatment needs vary according to the phase of the disease and the individual patient.
Most people with CML have a genetic change known as the Philadelphia chromosome. This change creates the BCR::ABL1 fusion gene, which produces an abnormal tyrosine kinase protein. That protein sends signals encouraging affected blood cells to grow uncontrollably.
Importantly, the Philadelphia chromosome associated with CML is acquired rather than inherited. It is not normally passed from a parent to a child.
This helps explain one aspect of Nivea’s original reaction. She said it was both relieving and puzzling to learn that she had not inherited the illness and had not done something to cause it.
A cancer diagnosis often brings an instinctive search for an explanation. Patients may wonder whether a decision, habit or family history is responsible. In CML, however, the cellular change usually occurs during a person’s lifetime, and doctors typically cannot identify one specific action that caused it.
Why remission is wonderful news—but not the same as a cure
The word “remission” understandably inspires celebration. It means that signs and symptoms of cancer have decreased or disappeared.
But it is important to use the term carefully.
The National Cancer Institute distinguishes between partial remission, in which some signs and symptoms have disappeared, and complete remission, in which all detectable signs and symptoms have disappeared. Even complete remission does not automatically prove that no cancer cells remain in the body.
Nivea did not publicly provide the detailed laboratory measurements needed to define her response further. Consequently, headlines declaring that she is definitively “cured” or completely “cancer-free” would go beyond what she has announced.
Her news is genuinely encouraging without exaggeration.
CML often requires continued medication and careful monitoring. Doctors may use blood counts, molecular testing and other examinations to check whether the level of abnormal cells remains controlled.
The need for monitoring does not make the remission announcement less important. It simply places the milestone in its proper context: this is a major piece of good news within an ongoing medical journey.